
Revisiting Post-Prostatectomy Salvage Radiation in the Age of Precision Oncology
This activity covers updates and evolving data in treating biochemically recurrent prostate cancer post-prostatectomy. One speaker covers fractionation: can we safely hypofractionate in the post-operative setting, or is the data more supportive of conventional fractionation? Several single institution studies have examined SBRT in this setting, is SBRT to the reconstructed post-RP pelvis ready for prime time? A second speaker addresses field and timing: in the era of SPPORT and POP-RT, do we recommend pelvic RT for everyone? And in the era of PSMA PET, have we learned anything about local patterns of failure that enable us to refine our prostate fossa target? Also, how "early" should early salvage radiation be - should we follow criteria from trials like RADICALS, or should we wait for a higher PSA to customize the field to a PSMA PET target? A third speaker from medical oncology addresses the use of systemic therapy with salvage radiation: with Decipher and Artera AI, what tools should we be using to inform the ADT decision for these patients? And is there adequate data to add androgen receptor pathway inhibitors for high-risk patients?
Topics:
- Is Hypofractionation the New Standard of Care for Salvage Post-prostatectomy Radiation?
Mark A. Buyyounouski, MD, MS, FASTRO - Rethinking Target and Timing for Salvage Post-prostatectomy Radiation
Stanley Liauw, MD, FASTRO - Choosing Systemic Therapy in the Salvage Setting
Michael Schweizer, MD - Q and A
Emily Steinberger Weg, MD – Moderator
Full Panel
This activity is available from February 17, 2026, through 11:59 p.m. Eastern time on February 16, 2028.
The content was originally presented and recorded at the 2025 ASTRO Annual Meeting.
Target Audience
The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, diagnostic radiologists and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Determine the most appropriate fractionation regimen to be used in the post-prostatectomy salvage radiation setting.
- Assess whether the pelvic nodes need to always be included in the post-prostatectomy salvage setting, and how to utilize PSMA PET data to inform the prostate bed target.
- Consider when to use hormone therapy for post-prostatectomy salvage radiation patients and which agents are most appropriate.
Course summary
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Moderator:
- Emily Steinberger Weg, MD, is employed by Weill Cornell Medical College. Dr. Weg has no relevant financial relationship with ineligible companies to disclose.
Speakers:
- Mark K. Buyyounouski, MD, MS, FASTRO, is employed by Stanford University School of Medicine. Dr. Buyyounouski has no relevant financial relationship with ineligible companies to disclose.
- Stanley Liauw, MD, FASTRO, is employed by University of Chicago. Dr. Liauw has no relevant financial relationship with ineligible companies to disclose.
- Michael Schweizer, MD, is employed by University of Washington. Dr. Schweizer has no relevant financial relationship with ineligible companies to disclose.
Planners:
- Malcolm Mattes, MD is employed at Rutgers Cancer Institute. Dr. Mattes received research/grant funding from Gilead Sciences (relationship ended 8/30/2025). Dr. Mattes has no relevant financial relationship with ineligible companies.
- Parul Barry, MD, is employed by the University of Pittsburgh Medical Center. Dr. Barry has no relevant financial relationship with ineligible companies.
- Michael Haddock, MD, is employed by Mayo Clinic and has no relevant financial relationship with ineligible companies to disclose.
- Manisha Palta, MD, is employed by Duke Cancer Center and Duke University Hospital. Dr. Palta receives grant/research funding from Merck and Varian Medical Systems.
- Salma Jabbour, MD, is employed by Rutgers Cancer Institute. Dr. Jabbour receives grant/research funding from Merck & Co., Inc. and Beigene. Dr. Jabbour receives compensation/payment as a consultant with Radialogica and IMX Medical.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Activity Fees
This activity is included in the ASTRO Academy Subscription. To purchase the subscription beginning December 1, 2026, please go to the ASTRO Product Catalog.
ASTRO members and Academy subscribers must log in to the ASTRO Academy to view and receive the corresponding rate:
- Academy Subscriber: $0
- Member: $99
- Member-in-Training / Student Member / Postdoctoral Fellow Member: $49
- Nonmember: $149
Discounts
Please email ASTRO eLearning to inquire about the discounts below.
- If you are an ASTRO member residing in a low- or lower-middle-income economy country, as identified by the World Bank, you can receive a 50% discount off the activity fee.
- If you are an ASTRO member residing in an upper-middle-income economy country, as identified by the World Bank, you can receive a 25% discount off the activity fee.
Policies
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until the Activity expiration date, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Copyright of all aspects of ASTRO Academy Content, including recordings and/or reproductions of sessions, programs, presentations, discussions and other scheduled events (“ASTRO Academy Content”) is owned by ASTRO. Only ASTRO reserves the rights to all ASTRO Academy Content, including to digitize, modify, alter, edit, adapt, create derivative works, display, publicly perform, exhibit, transmit, broadcast, reproduce, exploit, sell, rent license, otherwise use, and permit others to use, such ASTRO Academy Content. Photographing, filming, taping, recording or any form of capture or reproduction in any medium of any aspect of ASTRO Academy Content, including, but not limited to the programs, presentations, material, sessions, and discussions, or on the Academy platform are strictly forbidden without written authorization from ASTRO.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.

Facebook
X
LinkedIn
Forward